Latest Market News

Microba Life Sciences reports record Q4 FY25 microbiome test sales in Australia and the UK, underpinned by landmark clinical studies and a $14.5 million capital raise. The company is transitioning away from legacy products to focus on high-value diagnostics, positioning for sustained growth in FY26.

Sunrise Energy Metals reports strong high-grade scandium drill results at Syerston and secures $7.5 million to accelerate project development. The company is updating its feasibility study amid growing market demand and geopolitical supply pressures.

PPK Group’s majority-owned PowerPlus Energy launches two Clean Energy Council-approved batteries eligible for the Australian Government’s new Cheaper Home Batteries Program rebates, positioning itself to capture a significant share of the emerging residential energy storage market.

Praemium Limited reports a 2.2% increase in funds under administration for Q4 FY25, driven by strong gains in Spectrum and SMA platforms, alongside operational upgrades including AI-driven initiatives. However, OneVue platform experiences a significant decline.

Praemium reports a 12% rise in total Australian funds under administration to $64.3 billion in Q4 FY2025, driven by strong inflows into its Spectrum platform and growth in Separately Managed Accounts. However, Powerwrap continues to face net outflows.

Genetic Signatures reported steady quarterly sales of $4.4 million, reflecting seasonal demand in Australia, while restructuring its US operations to accelerate growth. A new US contract and strategic partnerships signal potential for future expansion.

Insignia Financial reported a 2.6% rise in Funds Under Management and Administration to $330.3 billion, driven by record net inflows into its MLC Expand platform and a successful Master Trust transition to SS&C.

Insignia Financial has agreed to a $4.80 per share acquisition offer from CC Capital, representing a 56.9% premium over its recent share price. The Board unanimously recommends the scheme, pending regulatory and shareholder approvals.

Genetic Signatures has formed a strategic partnership with Tecan and Repado to develop a fully automated, scalable infectious disease testing platform integrating advanced automation, compliant software, and proprietary assays.

88 Energy Limited reports significant progress on its Alaskan projects with a robust prospective resource base and advancing farm-out deals, while securing a key license extension in Namibia and negotiating asset divestment in Texas.

Volt Resources has drawn $0.5 million from a $1 million funding agreement to accelerate development of its graphite projects in Tanzania and the US, positioning itself amid rising US tariffs on Chinese graphite imports.

OMG Group Limited has reported a remarkable 253% increase in quarterly cash receipts for Q4 FY25, driving annual revenues up 63% to $4.13 million and positioning the company for further growth in FY26.